Thomas Brechenmacher
1 appearance in the program
Sessions & presentations
Statistical Methods for Clinical Trial Endpoints
First Author
Presentation: Seamless phase 2/3 design with Bayesian dose selection rule based on primary and surrogate endpoints
Contributed Papers · Mon, Aug 5 , 2:00 PM